What is Halaven 0.5 mg/ml Injection?

Halaven 0.5 mg/ml Injection is a prescription anticancer medicine containing Eribulin Mesylate as its active ingredient. It belongs to a class of medicines known as microtubule dynamics inhibitors, a type of chemotherapy drug used to treat certain advanced cancers.

Eribulin works by interfering with the normal process of cell division. Cancer cells multiply rapidly, and Halaven prevents them from completing this process, which ultimately causes the cancer cells to die while slowing the growth and spread of the disease.

Doctors commonly prescribe Halaven Injection for patients with:

• Locally advanced or metastatic breast cancer
• Certain patients with unresectable or metastatic liposarcoma who have previously received anthracycline-containing chemotherapy

Manufactured by Eisai, Halaven is widely recognized in oncology practice for treating cancers that have progressed after previous therapies.

Because this medicine is administered intravenously and may cause significant side effects, Halaven should only be used under the supervision of a qualified oncologist or healthcare professional.

---

Uses of Halaven 0.5 mg/ml Injection

Halaven is prescribed for specific cancer indications supported by clinical evidence.

Its approved uses include:

• Treatment of locally advanced breast cancer
• Treatment of metastatic breast cancer after prior chemotherapy
• Management of unresectable liposarcoma
• Treatment of metastatic liposarcoma in eligible patients
• Supportive therapy as part of an individualized cancer treatment plan

This medicine should only be taken under the supervision of a qualified healthcare professional.

---

Benefits of Halaven 0.5 mg/ml Injection

Halaven offers several therapeutic benefits when used in appropriately selected patients.

Benefits may include:

• Helps slow the growth of cancer cells
• May delay disease progression
• Supports management of advanced breast cancer
• Provides an additional treatment option after previous chemotherapy
• May improve symptom control in some patients
• Can help maintain quality of life during cancer treatment
• Supports individualized long-term cancer management

While Halaven can help control cancer progression, it is not considered a cure, and treatment outcomes vary among individuals.

---

How Does Halaven 0.5 mg/ml Injection Work?

Halaven contains Eribulin Mesylate, which acts on structures inside cells called microtubules.

Microtubules are essential for cell division. Cancer cells rely on these structures to multiply rapidly. Eribulin blocks the normal growth of microtubules, preventing cancer cells from completing cell division.

As a result:

• Cancer cell multiplication slows down.
• Abnormal cells are unable to survive.
• Tumor growth may be reduced.
• Disease progression may be delayed.

Because healthy cells can also be affected, treatment is carefully monitored by oncology specialists.

---

How to Take Halaven 0.5 mg/ml Injection

Halaven is not a self-administered medicine.

General guidance includes:

• It is given as an intravenous (IV) injection by a healthcare professional.
• Receive treatment exactly according to your oncologist’s schedule.
• Never attempt to inject this medicine yourself.
• Blood tests may be required before each treatment cycle.
• Attend all scheduled appointments.
• Inform your doctor if you miss an appointment so that a new schedule can be arranged.
• Never change or discontinue treatment without medical advice.

---

Side Effects of Halaven 0.5 mg/ml Injection

Like all medicines, Halaven may cause side effects, although not everyone experiences them.

Common Side Effects

• Fatigue
• Weakness
• Nausea
• Vomiting
• Constipation
• Hair loss
• Decreased appetite
• Peripheral neuropathy (numbness or tingling in hands and feet)
• Fever
• Muscle or joint pain
• Low white blood cell count (neutropenia)

Serious Side Effects

Seek immediate medical attention if you experience:

• Severe infection or fever
• Significant decrease in blood cell counts
• Difficulty breathing
• Chest pain
• Severe allergic reaction
• Irregular heartbeat or QT interval prolongation
• Severe numbness or worsening nerve damage
• Unusual bleeding or bruising

If side effects persist or become severe, contact your healthcare provider promptly.

---

Warnings and Precautions

Before receiving Halaven, inform your healthcare provider about your complete medical history.

Pregnancy

Halaven may harm an unborn baby. Effective contraception should be used during treatment and for the recommended period afterward.

Breastfeeding

Breastfeeding is generally not recommended during treatment because it is unknown whether the medicine passes into breast milk and may harm the infant.

Liver Disease

Patients with liver impairment may require dose adjustments and close monitoring.

Kidney Disease

Kidney function should be assessed before treatment, especially in patients with moderate to severe impairment.

Heart Disease

Halaven may affect heart rhythm, including QT interval prolongation. Patients with existing heart conditions require careful monitoring.

Elderly Patients

Older adults may be more susceptible to certain side effects and should be monitored closely.

Alcohol

Alcohol may worsen certain side effects such as dizziness or dehydration. Discuss alcohol use with your doctor.

Driving and Operating Machinery

If you feel tired, dizzy, or weak after treatment, avoid driving or operating heavy machinery.

Allergies

Do not receive Halaven if you have a known allergy to Eribulin Mesylate or any ingredient in the formulation.

---

Drug Interactions

Halaven may interact with other medicines, potentially affecting its safety or effectiveness.

Tell your doctor about all medicines you take, including:

• Prescription medications
• Over-the-counter medicines
• Herbal supplements
• Vitamins
• Mineral supplements

Particular caution may be needed with medicines that affect heart rhythm or bone marrow function. Your healthcare provider will determine whether any treatment adjustments are necessary.

---

Storage Instructions

Healthcare providers typically store Halaven according to the manufacturer’s recommendations.

General advice includes:

• Store at the temperature recommended by the manufacturer.
• Protect from excessive heat and direct sunlight.
• Do not freeze unless specifically instructed.
• Keep the vial in its original packaging until use.
• Keep out of reach of children.
• Do not use after the expiry date.
• Disposal should follow local medical waste regulations.

---

Disclaimer

This information is intended for educational purposes only and should not be considered medical advice. Halaven is a prescription chemotherapy medicine that must be used under the supervision of a qualified healthcare professional. Do not self-medicate or change your treatment plan without consulting your doctor. Individual responses to treatment may vary, and your healthcare provider is the best source of advice regarding your condition.

---

Frequently Asked Questions (FAQs)

1. What is Halaven Injection used for?

Halaven is primarily used to treat metastatic or locally advanced breast cancer after previous chemotherapy and certain patients with unresectable or metastatic liposarcoma.

2. How does Halaven work?

It contains Eribulin Mesylate, which blocks cancer cell division by interfering with microtubule formation, helping slow tumor growth.

3. Is Halaven chemotherapy?

Yes. Halaven is a chemotherapy medicine classified as a microtubule dynamics inhibitor.

4. Can Halaven be used long term?

Treatment duration depends on your response, side effects, and your oncologist’s recommendations. Regular assessments determine whether therapy should continue.

5. What happens if I miss a scheduled dose?

Contact your oncology clinic immediately. Do not attempt to reschedule or replace the dose on your own.

6. Can I stop Halaven treatment suddenly?

No. Treatment should only be stopped or changed after discussing it with your oncologist.

7. Can Halaven be taken with food?

Since Halaven is administered intravenously, food intake generally does not affect administration. Follow any dietary instructions provided by your healthcare team.

8. What are the most common side effects?

Common side effects include fatigue, nausea, hair loss, constipation, peripheral neuropathy, decreased appetite, and low white blood cell counts.

9. Who should avoid Halaven?

People with a known allergy to Eribulin Mesylate or those for whom the medicine is not medically appropriate should avoid it. Your doctor will determine whether it is suitable for you.

10. How should Halaven be stored?

Halaven should be stored according to the manufacturer’s recommendations by healthcare professionals, protected from excessive heat and light, and never used beyond its expiry date.